INFECTIONS AND TREATMENT JOURNAL
Matthew J. Sylte
Designation: Research Associate
Department: U.S. Department of Agriculture
American College of Veterinary Microbiologists
Country: United States
Dr. Matthew J. Sylte graduated from Kansas State University with a BA in microbiology in 1992 and a DVM in 1996. He then pursued a PhD in veterinary immunology at University of Wisconsin-Madison, and graduated in 2002. Afterward, he was a post-doc at Penn State and Michigan State from 2002-2004, where he studied oxidant stress and mammary gland biology in dairy cattle, and became a diplomate in the American College of Veterinary Microbiologists (immunology specialty). From 2004-2007, he worked at the Southeast Poultry Research Laboratory (USDA ARS) in Athens, GA, where he developing and testing efficacy of vaccines to protect against highly pathogenic avian influenza virus in chickens. Specifically, he focused on the use of neuraminidase as a vaccine antigen to protect chickens from highly pathogenic avian influenza-induced mortality. From 2007-2014, he worked at the University of Georgia in the department of infectious diseases as a non-tenured faculty member, where he taught in the veterinary curriculum and managed a research laboratory. From 2014 to present, he began working as a Research Veterinary Medical Officer at the National Animal Disease Center (USDA ARS; Ames, Iowa), in the Food Safety and Enteric Pathogens Research Unit.
Testing pre-harvest strategies to reduce Campylobacter colonization in commercial turkeys.
Open Access Journals
Subscribe to our Newsletter
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Recently Released Issues
Copyright © 2020 Boffin Access Limited.